サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1629860

ステアリン酸マグネシウムの世界市場（2024年～2031年）

Global Magnesium Stearate Market - 2024-2031

出版日
ページ情報
英文 201 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
ステアリン酸マグネシウムの世界市場（2024年～2031年）
出版日: 2024年12月30日
発行: DataM Intelligence
ページ情報: 英文 201 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ステアリン酸マグネシウムの世界市場は、2023年に5億3,333万米ドルに達し、2031年には8億5,125万米ドルに達すると予測され、予測期間2024年～2031年のCAGRは6.0%で成長する見込みです。

ステアリン酸のマグネシウム塩であるステアリン酸マグネシウムは、潤滑剤、固結防止剤、離型剤として広く利用されています。特に錠剤の結合剤やコーティング剤など、医薬品への応用が世界需要の大部分を占めています。さらに、ステアリン酸マグネシウムは、製造工程における一貫性と品質を確保する上で有用であるため、市場シェアの上昇に寄与しています。

ステアリン酸マグネシウムの世界市場は、医薬品、化粧品、食品など様々な産業での使用増加により、急速な成長を遂げています。国連（UN）によると、65歳以上の世界人口は2050年までに倍増し、15億人に達すると予想されています。この人口動態の変化は、高齢化により多くの医薬品を必要とするため、医薬品のステアリン酸マグネシウムに対する需要を大幅に増加させると思われます。

アジア太平洋はステアリン酸マグネシウムの急成長市場として浮上しており、医薬品と化粧品業界の力強い成長がその原動力となっています。アジア開発銀行（ADB）によると、同地域の医療費は大幅に増加する見込みで、インドや中国などの国々は医薬品生産に多額の投資を行っています。

インド・ブランド・エクイティ財団（IBEF）の報告によると、インドの医薬品輸出額は2023年に250億米ドルを突破しました。2024年4月だけで24億3,000万米ドル相当の医薬品が輸出され、2023年4月の22億6,000万米ドルから増加し、ステアリン酸マグネシウムのような賦形剤の大きな需要を生み出しています。

ダイナミクス

技術の進歩と用途の拡大

ステアリン酸マグネシウムの生産における技術的進歩は、その品質を著しく向上させ、応用範囲を広げています。製薬業界では、ステアリン酸マグネシウムは錠剤の完全性と安定性を保証し、ドラッグデリバリーシステムを改善します。ステアリン酸マグネシウムの微粉化などの最近の技術革新は、優れた性能と分散特性を提供し、主要市場の厳しい規制要件を満たしています。

化粧品業界では、ステアリン酸マグネシウムはフェイスパウダー、アイシャドー、口紅のテクスチャー向上剤として広く使用されています。Cosmetics Europeによると、欧州は化粧品とパーソナルケア製品の世界の主要市場であり続け、2023年の小売販売価格はおよそ950億米国ドルと評価されています。食品業界も、特に粉末食品や飲食品において、成分の凝集を防ぐ添加物としてステアリン酸マグネシウムを利用しています。

品質基準に対する意識の高まり

米国食品医薬品局（FDA）、欧州医薬品庁（EMA）、世界保健機関（WHO）などの主要機関が定める規制の枠組みは、ステアリン酸マグネシウム製品の安全性と有効性を確保する上で重要な役割を果たしています。これらの枠組みは、米国薬局方（USP）や欧州薬局方（EP）などの厳格な薬局方規格への準拠を強制し、メーカーに製造工程の革新と改良を強いています。

これらの規格を遵守することは、製品の品質を保証するだけでなく、メーカーが業務効率や製品処方を向上させる動機付けとなる市場競争環境を醸成します。その結果、企業は自社製品が規制要件に適合するだけでなく、より安全で効果的な医薬品賦形剤を求める消費者の進化する需要にも応えられるよう、こうした厳格なガイドラインを満たすことにますます注力するようになっています。

サプライチェーンの混乱と原材料コストの上昇

ステアリン酸マグネシウムの主原料はマグネシウムで、マグネサイトやドロマイトなどの鉱物から抽出される金属です。これらの原材料の価格は、供給不足や地政学的緊張などの要因により変動し、ステアリン酸マグネシウム製造のコスト構造に大きな影響を与えます。医薬品や食品加工に広く使用される賦形剤であるため、原料価格が不安定になると生産コストが上昇し、市場全体のダイナミクスに影響を及ぼす可能性があります。

さらに、食品添加物の安全性に関する懸念が高まっており、将来的に規制が厳しくなる可能性があります。規制機関は消費者の安全性を確保するために添加物の使用を精査するようになっており、ステアリン酸マグネシウム市場に課題をもたらす可能性があります。しかし、現在進行中の調査と規制認可の確立により、これらの懸念に効果的に対処し、安全性とステアリン酸マグネシウムが様々な用途で提供する機能的利点のバランスを維持することが期待されます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 技術の進歩とアプリケーションの拡大
      • 品質基準に対する意識の高まり
    • 抑制要因
      • サプライチェーンの混乱と原材料費の高騰
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • ロシア・ウクライナ戦争の影響分析
  • DMIの見解

第6章 用途別

  • 潤滑剤
  • 結合剤と充填剤
  • 乳化剤
  • 安定剤
  • その他

第7章 エンドユーザー別

  • 製薬
  • 食品・飲料
  • パーソナルケア
  • プラスチック
  • その他

第8章 サスティナビリティ分析

  • 環境分析
  • 経済分析
  • ガバナンス分析

第9章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋
  • 中東・アフリカ

第10章 競合情勢

  • 競合シナリオ
  • 市況・シェア分析
  • M&A分析

第11章 企業プロファイル

  • Thermo Fisher Scientific
    • 会社概要
    • 製品ポートフォリオと概要
    • 財務概要
    • 主な発展
  • PT Halim Sakti Pratama
  • Parchem Fine & Specialty Chemicals
  • Nimbasia
  • Baerlocher GmbH
  • Valtris Specialty Chemicals
  • FACI SPA
  • Merck KGaA
  • Kirsch Pharma GmbH
  • James M. Brown Ltd

第12章 付録

目次
Product Code: FB8915

Global Magnesium Stearate Market reached US$ 533.33 million in 2023 and is expected to reach US$ 851.25 million by 2031, growing with a CAGR of 6.0% during the forecast period 2024-2031.

Magnesium stearate, a magnesium salt of stearic acid, is extensively utilized as a lubricant, anti-caking agent and release agent. Its applications in pharmaceuticals, particularly as a tablet binder and coating agent, account for a significant portion of its global demand. Furthermore, magnesium stearate's utility in ensuring consistency and quality in manufacturing processes contributes to its rising market share.

The global magnesium stearate market is witnessing rapid growth, driven by its increasing use across various industries such as pharmaceuticals, cosmetics and food. According to the United Nations (UN), the global population aged 65 and above is expected to double by 2050, reaching 1.5 billion. This demographic shift will significantly increase the demand for magnesium stearate in pharmaceuticals, as aging populations require more medications.

Asia-Pacific is emerging as the fastest-growing market for magnesium stearate, driven by robust growth in the pharmaceutical and cosmetics industries. According to the Asian Development Bank (ADB), the region's healthcare expenditure is expected to rise significantly, with countries like India and China investing heavily in pharmaceutical production.

The India Brand Equity Foundation (IBEF) reports that India's pharmaceutical exports surpassed US$ 25 billion in 2023. The country exported US$ 2.43 billion worth of drugs and pharmaceuticals in April 2024 alone, up from US$ 2.26 billion in April 2023 creating substantial demand for excipients like magnesium stearate.

Dynamics

Technological Advancements and Expanding Applications

Technological advancements in magnesium stearate production have significantly enhanced its quality and broadened its application spectrum. In the pharmaceutical industry, magnesium stearate ensures tablet integrity and stability, improving drug delivery systems. Recent innovations, such as micronized magnesium stearate, offer superior performance and dispersion properties, meeting stringent regulatory requirements in key markets.

In the cosmetics industry, magnesium stearate is widely used as a texture-enhancing agent in face powders, eye shadows and lipsticks. According to Cosmetics Europe, Europe remains a global flagship market for cosmetics and personal care products, approximately valued at US$ 95 billion in retail sales price in 2023. The food industry also relies on magnesium stearate as an additive to prevent ingredient clumping, particularly in powdered foods and beverages.

Rising Awareness of Quality Standards

Regulatory frameworks established by key organizations such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA) and the World Health Organization (WHO) play a crucial role in ensuring the safety and effectiveness of magnesium stearate products. These frameworks enforce compliance with stringent pharmacopeial standards, including those set by US Pharmacopeia (USP) and the European Pharmacopoeia (EP), which compel manufacturers to innovate and refine their production processes.

Adherence to these standards not only guarantees product quality but also fosters a competitive market environment where manufacturers are incentivized to enhance their operational efficiencies and product formulations. As a result, companies are increasingly focusing on meeting these rigorous guidelines to ensure that their products not only comply with regulatory requirements but also meet the evolving demands of consumers for safer and more effective pharmaceutical excipients.

Supply Chain Disruptions and Rising Raw Material Costs

Magnesium stearate is primarily sourced from magnesium, a metal extracted from minerals such as magnesite or dolomite. The prices of these raw materials fluctuate due to factors like supply shortages or geopolitical tensions, which can significantly affect the cost structure of magnesium stearate production. As a widely used excipient in pharmaceuticals and food processing, any instability in raw material pricing can lead to increased production costs, impacting the overall market dynamics.

Additionally, there is growing concern regarding the safety of food additives, which may result in stricter regulations in the future. Regulatory bodies are increasingly scrutinizing the use of additives to ensure consumer safety, potentially posing challenges for the magnesium stearate market. However, ongoing research and the establishment of regulatory approvals are expected to address these concerns effectively, helping to maintain the balance between safety and the functional benefits that magnesium stearate provides in various applications.

Segment Analysis

The global magnesium stearate market is segmented based on application, end-user and region.

Increasing Demand from the Pharmaceutical Sector

The pharmaceutical industry is the largest consumer of magnesium stearate. This excipient plays a vital role in drug formulation, particularly due to its ability to enhance the compressibility and flowability of active pharmaceutical ingredients (APIs). As the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) projects that the biopharmaceutical market will exceed US$ 1.750-1.780 trillion by 2026, the demand for magnesium stearate is expected to rise significantly, reinforcing its status as a critical component in modern drug manufacturing.

Magnesium stearate serves multiple functions in pharmaceutical applications, primarily acting as a lubricant that reduces friction between particles during the manufacturing process. This property is essential for ensuring efficient production of tablets and capsules, as it prevents ingredients from sticking to machinery and promotes consistent dosing. Additionally, magnesium stearate aids in improving the flow properties of drug powders, which is crucial for handling and processing during production. Its indispensable role in enhancing the quality and efficacy of pharmaceuticals underscores its importance in the industry.

Geographical Penetration

Strong Consumer Awareness in North America

North America dominates the magnesium stearate market, largely due to its robust pharmaceutical and food processing industries. The U.S. Food and Drug Administration (FDA) plays a critical role in this sector by emphasizing the necessity for high-quality excipients, which compels domestic manufacturers to adhere to stringent compliance and quality standards. According to the Centers for Medicare & Medicaid Services, in the U.S. healthcare spending grew 4.1% in 2022, reaching US$ 4.5 trillion or US$ 13,493 per person, highlighting the substantial demand for magnesium stearate within these industries.

The focus on magnesium stearate's quality is further reinforced by the FDA's regulations, which require manufacturers to ensure that their excipients meet the standards set by US Pharmacopeia (USP) and National Formulary (NF). This regulatory oversight is crucial as it not only safeguards patient safety but also maintains the integrity of drug formulations. Consequently, manufacturers are increasingly investing in quality assurance processes to comply with these regulations, ensuring that magnesium stearate and other excipients are safe and effective for use in pharmaceutical applications.

Competitive Landscape

The major global players in the market include Thermo Fisher Scientific, PT Halim Sakti Pratama, Parchem Fine & Specialty Chemicals, Nimbasia, Baerlocher GmbH, Valtris Specialty Chemicals, FACI SPA, Merck KGaA, Kirsch Pharma GmbH and James M. Brown Ltd.

Sustainability Analysis

The magnesium stearate market is increasingly prioritizing sustainability as manufacturers adopt energy-efficient processes and explore biodegradable formulations. These initiatives are crucial for meeting global sustainability goals and responding to rising consumer demand for eco-friendly products. According to the Global Sustainability Council for Chemicals (GSCC), the shift towards sustainable practices is not just a trend but a necessary evolution in the industry, aligning with broader environmental objectives.

Leading companies in the magnesium stearate sector are focusing on innovative production methods that minimize environmental impact. This includes the use of renewable resources and the development of formulations that reduce reliance on non-biodegradable materials. As sustainability becomes a key factor in purchasing decisions, manufacturers recognize the importance of adapting to these changes to remain competitive and relevant in a market that increasingly values ecological responsibility.

Advanced Material Innovations in the Magnesium Stearate Market

Innovations in material science and production processes are significantly shaping the magnesium stearate market. One of the most notable innovations in the magnesium stearate market is the development of nano-formulations. The ultra-fine particles of magnesium stearate enhance the flowability and uniformity of powders used in tablet and capsule manufacturing. The use of nano-sized magnesium stearate improves the consistency of active pharmaceutical ingredients (APIs) in solid dosage forms, ensuring better performance and drug release characteristics.

Similarly, innovations in drug delivery systems, such as controlled and sustained-release formulations, are driving the demand for specialized grades of magnesium stearate. Advanced drug formulations that require precise control over the release rate of the active ingredient benefit from the lubrication properties of magnesium stearate. New formulations are being developed to improve their compatibility with different types of APIs, including those that are poorly soluble in water, to enhance the bioavailability and therapeutic effectiveness of drugs.

By Application

  • Lubricants
  • Binders and Fillers
  • Emulsifiers
  • Stabilizers
  • Others

By End-User

  • Pharmaceutical
  • Food & Beverage
  • Personal Care
  • Plastics
  • Other

By Region

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In August 2023, Peter Greven, a leading producer of oleochemical additives and auxiliary products, made a strategic move to strengthen its foothold in the Chinese market. The company announced the purchase of a new plant for the production of magnesium stearate, a move that is expected to enhance its position in China across several product categories.
  • In September 2023, Elite Chemicals, a renowned pharmaceutical company, announced the launch of a new line of magnesium stearate products specifically designed for the food industry. These products are gluten-free and non-GMO, addressing the evolving needs of the food sector, where clean labels and healthy ingredients are becoming increasingly important.
  • On August 2, 2022, SK Capital Partners, a private investment firm based in New York with a focus on specialty chemicals, materials and pharmaceuticals, announced the completion of its acquisition of Valtris Specialty Chemicals from H.I.G. Capital. The acquisition strengthens SK Capital's portfolio in the specialty chemicals sector and is expected to drive further innovation and market expansion for Valtris, particularly in the development of key chemical products such as magnesium stearate.

Why Purchase the Report?

  • To visualize the global magnesium stearate market segmentation based on application, user and region.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points at the magnesium stearate market level for all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global magnesium stearate market report would provide approximately 54 tables, 46 figures and 201 pages.

Target Audience 2024

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Application
  • 3.2. Snippet by End-User
  • 3.3. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Technological Advancements and Expanding Applications
      • 4.1.1.2. Rising Awareness of Quality Standards
    • 4.1.2. Restraints
      • 4.1.2.1. Supply Chain Disruptions and Rising Raw Material Costs
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. By Application

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 6.1.2. Market Attractiveness Index, By Application
  • 6.2. Lubricants*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Binders and Fillers
  • 6.4. Emulsifiers
  • 6.5. Stabilizers
  • 6.6. Others

7. By End-User

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 7.1.2. Market Attractiveness Index, By End-User
  • 7.2. Pharmaceutical*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Food & Beverage
  • 7.4. Personal Care
  • 7.5. Plastics
  • 7.6. Other

8. Sustainability Analysis

  • 8.1. Environmental Analysis
  • 8.2. Economic Analysis
  • 8.3. Governance Analysis

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.5.1. US
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.5.1. Germany
      • 9.3.5.2. UK
      • 9.3.5.3. France
      • 9.3.5.4. Italy
      • 9.3.5.5. Spain
      • 9.3.5.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. Brazil
      • 9.4.5.2. Argentina
      • 9.4.5.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. China
      • 9.5.5.2. India
      • 9.5.5.3. Japan
      • 9.5.5.4. Australia
      • 9.5.5.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Thermo Fisher Scientific*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
  • 11.2. PT Halim Sakti Pratama
  • 11.3. Parchem Fine & Specialty Chemicals
  • 11.4. Nimbasia
  • 11.5. Baerlocher GmbH
  • 11.6. Valtris Specialty Chemicals
  • 11.7. FACI SPA
  • 11.8. Merck KGaA
  • 11.9. Kirsch Pharma GmbH
  • 11.10. James M. Brown Ltd

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us